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Objective: Surgical treatment of arterial lesions associated with Behçet disease (BD) is often complicated by graft occlusion
and recurrence of aneurysms. The purpose of this study was to clarify the long-term outcome of surgical intervention for
arterial involvement in BD.
Methods:Ten patients with BD (9 men, 1 woman) who underwent surgical treatment for arterial aneurysms between 1980
and 2004 were included in the study. The age of patients at the first operation ranged from 36 to 69 years (mean, 50.4
 9.0 years). The mean period between the onset of BD and that of arterial manifestations was 8.0  5.0 years. We
retrospectively reviewed their postoperative courses, including survival, graft occlusion, formation of anastomotic false
aneurysms, and the development of aneurysms at different sites. The Kaplan-Meier method was used to calculate the
chronologic incidence of complications after surgery.
Results: The mean follow-up period was 133  92 months, ranging from 5 to 285 months. One patient died of rupture
of a dissecting aortic aneurysm after undergoing several surgical interventions for multiple aneurysms. There were five
graft occlusions among 21 grafts. The cumulative primary graft patency rate in the infrainguinal region was 83.9% at 3
years. Five anastomotic false aneurysms formed among 49 anastomoses between grafts and host arteries. The overall
cumulative incidence of formation of anastomotic pseudoaneurysm was 12.9% at 5 and 10 years. All of them formed
within 18 months after surgery. Development of new aneurysms in different arteries was observed in two patients.
Conclusions: Early occurrence of anastomotic false aneurysm is characteristic of BD. Further investigation is necessary to
establish effective postoperative treatment. (J Vasc Surg 2005;42:116-21.)Behçet disease (BD) is a chronic multisystemic disorder
typically characterized by the triad of recurrent oral and
genital ulceration and relapsing uveitis. The etiology re-
mains unknown, but it is speculated that autoimmunity
triggered by bacterial or viral infection or other environ-
mental factors plays a role.1,2 The various clinical mani-
festations of the disease include mucocutaneous, ocular,
articular, neurologic, cardiovascular, gastrointestinal, and
pulmonary involvement. The underlying histopathologic
feature is systemic vasculitis affecting veins, arteries, and
capillaries.3
Arterial involvement in the disease is rare, but aneurysm
formation frequently is complicated by fatal rupture, which
makes surgical treatment necessary.4 However, surgeons
often are challenged by graft occlusion and aneurysm for-
mation at the anastomotic site or in other arteries during
the postoperative course.4-10 Yet, because of the rarity of
the disease, there is little information about the incidence of
complications after vascular surgery in patients with BD. In
this study, we retrospectively reviewed the postoperative
course of patients with BD with arterial involvement who
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116underwent surgical intervention, to clarify the long-term
outcome of treatment.
METHODS
The study included 10 patients with BD with arterial
involvement (9 men, 1 woman) who underwent surgical
treatment between 1980 and 2004. The diagnosis of BD
was confirmed using the criteria of the International Study
Group for Behçet’s Disease.11 Six of the male patients were
smokers. The female patient had a history of hypertension;
other patients did not have a medical history of hyperten-
sion, hyperlipidemia, or diabetes mellitus. Six patients had a
history of venous involvement; 3 had a history of superficial
thrombophlebitis, 2 had a history of deep venous throm-
bosis, and 1 had a history of both. No patient had the
complication of pulmonary artery aneurysm. In all cases,
the first surgical intervention was performed for aneurysmal
lesions. The age of patients at the time of the first operation
ranged from 36 to 69 years, with a mean  standard
deviation of 50.4  9.0 years. The mean period between
the onset of BD and that of vascular manifestation was 8.0
5.0 years, ranging from 0 to 16 years. There was no
operative death during the study period.
We investigated the long-term postoperative outcome,
including survival, graft occlusion, formation of anasto-
motic false aneurysms, and development of aneurysms at
different sites. The postoperative follow-up protocol of our
institution included careful physical examination and mea-
surement of ankle and brachial blood pressures every 1 to 6
months. Since the late 1980s, regular surveillance using
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additionally has been performed every 6 to 12 months. The
diagnosis of anastomotic pseudoaneurysm was confirmed
by intraoperative macroscopic findings or postoperative
pathologic examination. In cases of graft occlusion, the
proximal anastomosis was kept in the follow-up for analysis
of the formation of anastomotic false aneurysms because
it continued to be exposed to systemic blood pressure.
On the other hand, the distal anastomosis exposed to low
blood pressure after graft occlusion was excluded from the
analysis.
Data are presented as mean standard deviation unless
otherwise stated. The Kaplan-Meier method was used to
calculate the chronologic primary patency rate of the graft
and the occurrence of anastomotic false aneurysm.
RESULTS
The profiles of arterial lesions and surgical interventions
and the postoperative course are summarized in Tables I
and II. The graft material was selected according to the
operator’s choice. All anastomoses were made using a wide-
bite running suture technique. Endarterectomy was not
performed in any of the cases. Autogenous veins used for
Table I. Profiles of arterial lesions and operations
Case
Age at
operation Indication for operation
1 58 Thoracoabdominal aortic aneurysm
2 53 AAA  right CIA aneurysm
3 53 Left CFA aneurysm
57 Occlusion of HUVG
57 Aneurysmal degeneration of HUVG
58 ANA between wDG and HUVG
60 Aneurysmal degeneration of HUVG
61 Occlusion of kDG
65 ANA between kDG and AVG
4 55 Left SFA aneurysm
56 ANA at popliteal artery
57 ANA at CFA  occlusion of AVG
57 ANA between kDG and AVG
58 ANA between kDG and AVG
58 Infection of kDG
5 69 Right SFA aneurysm
6 46 Right popliteal aneurysm
58 ANA at popliteal artery  occlusion of
7 47 Left popliteal aneurysm
47 Bilateral CIA aneurysm
51 Occlusion of popliteal graft
58 Left SFA aneurysm
60 Aortic dissection (Stanford A type)
60 Right popliteal aneurysm
8 44 Left popliteal aneurysm
44 Infection of kDG
9 36 Right axillary aneurysm
10 50 Left axillary aneurysm
50 ANAs at axillary and brachial arteries
50 Increased size of distal ANA
wDG, Woven Dacron graft; AAA, abdominal aortic aneurysm; CIA, commo
femoral artery; kDG, knitted Dacron graft; HUVG, glutaraldehyde-tanned h
aneurysm; PTA, posterior tibial artery; AVG, autogenous vein graft; SFA, sgrafts were closely examined preoperatively and intraop-eratively to exclude pre-existing changes associated with
the disease. Postoperative medication was determined by
the rheumatologists at our institution and depended on the
systemic inflammatory status and general condition of each
patient and on the side effects of the drugs. The mean
follow-up period was 133 92 months, ranging from 5 to
285 months. Two patients (cases 6 and 10) were lost to
follow-up (at 228 and 68 months after the first operation,
respectively). One patient (case 7) died during the study
period.
We experienced five graft occlusions, all of which oc-
curred among 14 grafts in the infrainguinal region (inci-
dence per graft, 35.7%). The cumulative primary graft
patency rate  standard error in this region was 83.9% 
10.4% at 3 years. Five grafts in the aortic or iliac region and
2 in the upper extremity remained patent.
A total of 5 anastomotic false aneurysms formed among
49 anastomoses between the graft and the host artery
(incidence per anastomosis, 10.2%); 2 anastomotic false
aneurysms each in cases 4 and 10, and 1 in case 6. Of them,
1 formed at the proximal anastomosis of the femoral artery,
2 at the distal anastomosis of the popliteal artery, 1 at
Surgical procedure
Tube graft (wDG)  visceral arterial reconstruction
Bifurcated graft (aortobiiliac, wDG)
EIA-DFA bypass (kDG)  kDG-popliteal bypass (HUVG)
kDG-TP trunk bypass (HUVG)
Interposition (wDG)
Interposition (HUVG)
CIA-TP trunk bypass (kDG)
Thrombectomy  kDG-PTA bypass (AVG)
Interposition (kDG)
Femoropopliteal bypass (kDG)
EIA-popliteal bypass (AVG)
EIA-AVG bypass (AVG)
Interposition (kDG)
Interposition (kDG)
Resection of graft  right SFA-left popliteal bypass (AVG)
SFA-popliteal-peroneal sequential bypass (AVG)
Interposition (AVG)
Interposition (AVG)
Interposition (kDG)
Bifurcated graft (kDG)
SFA-PTA bypass (AVG)
SFA-AVG bypass (AVG)
Graft replacement (wDG)
Ligation  bypass (AVG)
Interposition (kDG)
Resection of graft  SFA-TP trunk bypass (AVG)
Interposition (AVG)
Exclusion  bypass (AVG)
Ligation of subclavian artery
Aneurysmectomy
artery; CFA, common femoral artery; EIA, external iliac artery; DFA, deep
umbilical vein graft; TP trunk, tibioperoneal trunk; ANA, anastomotic false
cial femoral artery.AVG
n iliacthe proximal anastomosis of the axillary artery, and 1 at
t; TAA
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per anastomosis was: infrainguinal, 3 of 27 anastomoses
(11.1%); aortic or iliac, 0 of 18 anastomoses (0%); upper
extremity, 2 of 4 anastomoses (50%). Two formed at the
anastomosis of a knitted Dacron graft (2 of 24 anastomoses
of Dacron grafts, 8.3%), and the other 2 at the anastomosis
of an autogenous vein graft (3 of 23 anastomoses, 13.0%).
The mean interval between the operation and the diagnosis
of anastomotic false aneurysm was 10.8  5.1 months,
ranging from 6 to 17 months. The overall cumulative
incidence of anastomotic false aneurysm  standard error
was 12.9%  5.4% at 5 and 10 years (Figure).
Three patients had aneurysms of different arteries, ei-
ther simultaneously or metachronously. An aneurysm of
the superficial femoral artery (SFA), 19 mm in diameter,
was found 5 years after surgical treatment of an aneurysm of
the contralateral common femoral artery (CFA) in case 3.
Table II. Profiles of postoperative course and number of
aneurysms of different arteries
Case Medication
Graft
occlusion
Anastomotic
false aneurysm
N
1 C — —
2 C, CS — —
3 AC, AP 2 —
4 AP 1 2
5 C, CS, AC — —
6 C, AP 1 1
7 AC, AP 1 —
8 AC — —
9 C — —
10 AP — 2
C, Colchicine; CS, corticosteroid; AC, anticoagulant; AP, antiplatelet agen
Cumulative incidence of anastomotic false aneurysThe lesion has been under close observation for 12 years,and had enlarged to reach 28 mm in diameter at the last
follow-up. Surgical intervention is now under consider-
ation. This patient underwent two operations for aneurys-
mal degeneration of a glutaraldehyde-tanned human um-
bilical vein graft. Pathologic examination of the aneurysmal
parts of the impaired grafts revealed no specific findings
characteristic of BD. In case 5, an infrarenal abdominal
aortic aneurysm, 3 cm in diameter, was diagnosed at the
same time as an aneurysm of the SFA. The aneurysm of the
SFA was treated surgically, and the aortic aneurysm has
been under observation. The size of the latter has not
changed during 6 months of follow-up. Metachronous
multiple aneurysms of the bilateral popliteal and common
iliac arteries, SFA, and ascending aorta developed in one
patient (case 7), all of which were treated surgically. Twenty-
four years after the first operation for popliteal aneurysm,
the patient died of rupture of an acute dissecting aneurysm
ded grafts, anastomotic false aneurysms, and new
neurysms at
erent sites
Duration of
follow-up (months) Final status
— 160 Alive
— 98 Alive
1 212 Alive
— 44 Alive
— 6 Alive
— 228 Lost to follow-up
6 173 Died, rupture of TAA
— 53 Alive
— 285 Alive
— 68 Lost to follow-up
, thoracic aortic aneurysm.
er bypass grafting in patients with Behçet disease.occlu
ew a
diffof the descending aorta.
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Previous studies documented that the prevalence of
arterial involvement ranged from 2.2% to 18%, with marked
male predominance.4,12-17 A high proportion of cases with
arterial lesions are also complicated by venous involve-
ment.7,17 The reported interval between the onset of BD
and that of arterial manifestation is 5 to 9 years.4,7,8,17 In
the present series of 10 cases, 9 patients were male, 6 had a
history of venous complications, and the mean duration of
BD before the initial arterial manifestations was 8.0 years,
which were comparable with previous reports. The reason
for the predominance of vascular involvement in male
subjects remains unclear. Six of 9 male patients included in
the present study were smokers, while none of them had
other cardiovascular risk factors. In the series of 25 cases
with arterial lesions in BD (23 men and 2 women) reported
by Le Thi Huong et al,7 no patient had cardiovascular risk
factors except for 1 smoker. Taking these data into account,
the male predominance cannot be explained only by factors
predisposing to the atherosclerotic changes in vessels. On
the other hand, the influence of sex hormones or genetic
peculiarity has been indicated.18,19
Although occlusive lesions tend to take a rather benign
course, aneurysms complicating BD are apt to grow rapidly
and sometimes result in fatal rupture. 4,7,8,20,21 Because of
the risk of rupture, aneurysmal lesions in BD should be
treated surgically if they are large or are increasing in size.
However, the postoperative course is often complicated by
graft occlusion and recurrence of aneurysms, leading to a
relatively high mortality rate. Indeed, the cause of death of
the only patient who died during the study period in the
present series was rupture of an acute dissecting aneurysm
of the descending aorta, which followed multiple aneu-
rysms. The survival rate after the onset of arterial involve-
ment in BD is reported to be 83% and 66% at 5 and 15
years, respectively, showing a poorer prognosis of BD with
arterial lesions compared with the overall survival rate of
patients with BD.7,17,22
Pathologically, arterial lesions in BD are characterized
by intense inflammation primarily involving the media and
adventitia.23 A specific histologic feature of BD is leukocyte
accumulation around the vasa vasorum.24 Infiltration of
inflammatory cells, mainly neutrophils, lymphocytes, and
plasma cells, leads to destruction of the media and fibrous
thickening of the intima and adventitia. Weakening of the
arterial wall causes distention of the vessel, with subsequent
formation of a true aneurysm, or perforation of the vessel
wall, triggering development of a false aneurysm or arterial
dissection.24 The most common site of aneurysm forma-
tion is the aorta, followed by the pulmonary and femoral
arteries.4,7,20 Vessel occlusion associated with BD can also
be attributed to intimal thickening and endothelial dys-
function caused by vasculitis. Ozoran et al25 documented a
high plasma level of von Willebrand factor induced by
inflammation of vessels, which could enhance platelet ag-
gregation, and a high level of plasminogen activator inhib-
itor caused by platelet accumulation on the damaged endo-thelial surface, which might inhibit fibrinolytic activity. On
the other hand, Guermazi et al26 reported that acquired
protein S deficiency caused by autoantibodies might be one
of the causes of thrombogenicity of BD. The presence of
anticardiolipin antibodies in patients with BD has been
shown in several studies.27,28 These underlying thrombotic
diatheses might predispose to the development of occlusive
changes in vessels.
We could not investigate the cause of graft occlusions
because pathologic examination of the occluded grafts was
not performed in any of the cases. Systemic procoagulative
tendency and intimal thickening caused by inflammation of
native arteries may be an explanation for the high incidence
of postoperative graft occlusion. Le Thi Huong et al7 expe-
rienced six graft occlusions in 10 patients with BD who
underwent bypass grafting during a mean follow-up period
of 69 months. Tuzun et al8 reported that of 17 patients
with BD who were treated with arterial bypass surgery,
graft occlusion developed in 3 during a mean follow-up
period of 47 months. In our series, grafts became occluded
in 4 of 10 patients during a relatively longer mean follow-up
of 133 months, with a cumulative primary patency rate of
83.9% at 3 years in the infrainguinal region. All of the four
patients had been treated with antiplatelet therapy postop-
eratively, and two had also received anticoagulants. More
intense preventive measures, including high-intensity anti-
coagulant therapy, might be necessary to prevent graft
occlusion in patients with BD.
Anastomotic pseudoaneurysm is another postoperative
complication that is considered to occur frequently in BD
patients and is sometimes life-threatening, although its
incidence has never been elucidated. We encountered 5
anastomotic false aneurysms among 49 anastomoses be-
tween the graft and the host artery during the study period,
with a cumulative incidence of 12.9% at 5 and 10 years. We
excluded anastomoses between the grafts from the analysis
because the relationship between BD and complications at
these anastomoses is not clear. On the other hand, the
anastomotic false aneurysms formed in case 4 were included
because graft infection occurred after the formation of
pseudoaneurysms and we considered that they were prob-
ably related to BD.
Because all of the patients in the present study, includ-
ing those who were operated on in the early 1980s, have
undergone surveillance imaging using either echography,
angiography, or computed tomography, we consider that
the possibility of missing anastomotic pseudoaneurysms is
very low. The reported incidence of anastomotic pseudo-
aneurysm after vascular reconstruction in patients with
atherosclerotic disease varies from 2% to 15% per anasto-
mosis depending on the length of follow-up, site of anas-
tomosis, and method of diagnosis.29-31 A previous study
from our institution documented that the incidence of
anastomotic false aneurysm after surgical treatment of pa-
tients with Takayasu arteritis, another disease with systemic
noninfectious vasculitis, was 8.2% during a mean follow-up
of 17 years, excluding anastomoses made distal to the
femoral artery.32 This rate is comparable to the incidence of
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the present series (2 of 22 anastomoses). Taking these data
into account, we could not reach a conclusion that there
seems to be a higher risk of formation of anastomotic false
aneurysms in patients with BD compared with that in
atherosclerotic disease or Takayasu arteritis. However, a
notable observation in the present study was that all anas-
tomotic false aneurysms were detected within 18 months
postoperatively. McCabe et al33 reported that the develop-
ment of anastomotic false aneurysm of the femoral artery
was diagnosed an average of 6.2 years after surgery in
patients with atherosclerotic disease. In patients with Taka-
yasu disease, the mean interval between the operation and
the diagnosis of anastomotic false aneurysm was 9.8
years.32 The anastomotic fragility in patients with BD
might be attributable to weakening of the arterial wall
caused by fulminant inflammation. The early occurrence of
anastomotic false aneurysm indicates the difficulty in deter-
mining an appropriate site for anastomosis of a graft with
solid arterial wall, preoperatively or intraoperatively. Mac-
roscopic inspection might not be sufficient to clearly iden-
tify a disease-free portion of artery. As for the graft material,
we preferred Dacron grafts to expanded polytetrafluroeth-
ylene grafts because of easy handling and good healing
characteristics. We cannot reach any conclusion on the
optimal graft type or useful surgical technique to avoid
anastomotic complications because of the small number of
cases included in the present study. However, suturing with
wide bites at vessels distant from the diseased artery, if
possible, might lower the risk, as recommended for surgical
treatment of atherosclerotic disease.
Tuzun et al8 introduced ligation as a means of surgical
treatment for extremity aneurysms, because the likelihood
of finding an intact artery is low in BD patients. They
reported 8 cases of extremity aneurysms (1 carotid, 1
subclavian, 4 superficial femoral, 1 popliteal, and 1 poste-
rior tibial artery aneurysm) treated with ligation after con-
firming an adequate stump pressure. In our series, a subcla-
vian artery was ligated without disabling ischemia in one
patient (case 10) after formation of two anastomotic false
aneurysms after bypass grafting. This approach could be an
effective treatment without the risk of anastomotic compli-
cations in some circumstances. However, it could result in
significant functional impairment of the limb. We have
therefore opted for bypass grafting as the first choice of
intervention to secure a good functional outcome. Re-
cently, Park et al34 showed the possible usefulness of stent-
graft insertion in the management of aneurysms in BD.
Because the outcome of this technique in the long term
remains unclear, we have not considered using it in patients
with BD. Further investigation with longer follow-up
would elucidate the safety and effectiveness of stent-graft
placement for arterial lesions in BD.
Postoperative corticosteroid therapy and systemic im-
munosuppression with azathioprine, chlorambucil, or cy-
clophosphamide have been suggested as efficacious preven-
tive medication for arterial relapse including the formation
of aneurysms at anastomotic sites and in other arteries.7,8 Inthe present series, two of the patients were treated with
corticosteroids and none was treated with immunosuppres-
sive drugs after surgical intervention. One patient who
received corticosteroid therapy (case 2) has had no arterial
relapse for 98 months postoperatively; the other (case 5)
has had no sign of recurrence for 5 months, either, with no
change in size of an untreated aortic aneurysm. On the
other hand, 5 of 8 patients who were not under corticoste-
roid treatment have experienced new aneurysm formation.
We cannot reach any conclusion regarding the effectiveness
of postoperative steroid administration from our data, but
it is likely that patients without corticosteroid or immuno-
suppressive therapy are highly susceptible to recurrence of
arterial lesions. Further studies are necessary to clarify
whether postoperative medical treatment can improve the
prognosis of patients with BD with arterial involvement.
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